Vaxcyte
Price & Volume
Stats
See more52W Range | $29.08-$65 |
Market Cap | $8.4B |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$75M |
Diluted EPS | -$6.89 |
News
See moreYahoo Finance • 6 days ago
Vaxcyte to Participate in Upcoming Investor Conferences
Yahoo Finance • 22 days ago
Vaxcyte (PCVX) Doses Its First Patient in a Trial for a Disease With No Existing Vaccine
Yahoo Finance • 27 days ago
Vaxcyte (PCVX) Conducts Initial Dosage for VAX-A1 Phase 1 Study
Yahoo Finance • last month
Trevi Therapeutics Is Up 100%, Pivotal bioVenture Adds Anyway. Here's Why That Matters.
About
CEO | Mr. Grant E. Pickering M.B.A. |
CFO | Mr. Andrew L. Guggenhime M.B.A. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 507 |